CYCC logo

Cyclacel Pharmaceuticals (CYCC) Net Income

Annual Net Income

-$22.55 M
-$1.36 M-6.40%

December 31, 2023

Summary

Performance

1-Year Change

-6.4%

3-Year Change

-167.08%

5-Year Change

-209.48%

15-Year Change

-201.94%

CYCC Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.3%
CYCC annual net profit is higher than 54.3% of companies in Healthcare sector

High & Low

All-time High

$193.30 M
CYCC annual net profit is currently -111.67% below its historical high of $193.30 million

3-Year Low

-$22.55 M
CYCC annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CYCC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 19, 2025
CYCC next annual earnings announcement is scheduled for Mar 19, 2025

OtherCYCCprofitabilitymetrics:

Annual Net Margin

-5370.24%
CYCC annual net profit margin is -5370.24%

Annual Revenue

$420.00 K
CYCC annual revenue is $420.00 thousand

Annual Gross Profit

-
CYCC annual gross profit value is unknown

Annual EPS

-$26.75
CYCC annual earnings per share is -$26.75

Quarterly Net Income

-$1.96 M
+$1.30 M+39.91%

September 30, 2024

Summary

Performance

3-Month Change

+39.91%

1-Year Change

+62.87%

3-Year Change

+66.28%

5-Year Change

+66.28%

CYCC Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.01%
CYCC quarterly net profit is higher than 69.01% of companies in Healthcare sector

High & Low

All-time High

$1.49 M
CYCC quarterly net profit is currently -231.17% below its historical high of $1.49 million

3-Year Low

-$7.42 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CYCC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
CYCC next earnings announcement is scheduled for Mar 19, 2025

OtherCYCCprofitabilitymetrics:

Quarterly Net Margin

-19.57 K%
CYCC quarterly net profit margin is -19.57 thousand%

Quarterly Revenue

$10.00 K
CYCC quarterly revenue is $10.00 thousand

Quarterly Gross Profit

-
CYCC quarterly gross profit value is unknown

Quarterly EPS

-$0.18
CYCC quarterly earnings per share is -$0.18

TTM Net Income

-$13.43 M
+$4.08 M+23.28%

September 30, 2024

Summary

Performance

3-Month Change

+23.28%

1-Year Change

+40.45%

3-Year Change

+41.33%

5-Year Change

+41.33%

CYCC TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.76%
CYCC TTM net profit is higher than 63.76% of companies in Healthcare sector

High & Low

All-time High

-$3.84 M

3-Year Low

-$24.70 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CYCC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
CYCC next earnings announcement is scheduled for Mar 19, 2025

OtherCYCCprofitabilitymetrics:

Annual Net Margin

-5370.24%
CYCC annual net profit margin is -5370.24%

TTM Revenue

$74.00 K
CYCC TTM revenue is $74.00 thousand

TTM Gross Profit

-
CYCC TTM gross profit value is unknown

TTM EPS

-$9.40
CYCC TTM earnings per share is -$9.40

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$22.55 M
CYCC annual net profit is -$22.55 million

Annual Revenue

$420.00 K
CYCC annual revenue is $420.00 thousand

Annual Cost Of Goods Sold

-
CYCC annual cost of goods sold value is unknown

Annual Operating Expenses

$25.87 M
CYCC annual total operating expenses is $25.87 million

Annual Interest Expense

-
CYCC annual interest expense value is unknown

Annual Income Tax

-$3.00 M
CYCC annual income tax is -$3.00 million

CYCC Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.4%+62.9%+40.5%
3 y3 years-167.1%+66.3%+41.3%
5 y5 years-209.5%+66.3%+41.3%

CYCC Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.2%at lowat high+73.6%at high+45.6%
5 y5-year-188.1%at low-60.4%+73.6%-86.3%+45.6%
alltimeall time-111.7%+44.1%-231.2%+89.3%-249.5%+69.3%

Cyclacel Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.96 M(-39.9%)
-$13.43 M(-23.3%)
Jun 2024
-
-$3.26 M(+10.6%)
-$17.51 M(-11.1%)
Mar 2024
-
-$2.95 M(-44.1%)
-$19.70 M(-12.7%)
Dec 2023
-$22.55 M(+6.4%)
-$5.27 M(-12.6%)
-$22.55 M(-8.7%)
Sep 2023
-
-$6.03 M(+10.7%)
-$24.70 M(+3.9%)
Jun 2023
-
-$5.45 M(-6.1%)
-$23.77 M(+3.8%)
Mar 2023
-
-$5.80 M(-21.8%)
-$22.89 M(+8.0%)
Dec 2022
-$21.20 M(+14.9%)
-$7.42 M(+45.6%)
-$21.20 M(+13.7%)
Sep 2022
-
-$5.10 M(+11.4%)
-$18.64 M(+0.6%)
Jun 2022
-
-$4.58 M(+11.4%)
-$18.53 M(-2.9%)
Mar 2022
-
-$4.11 M(-15.5%)
-$19.09 M(+3.4%)
Dec 2021
-$18.46 M(+118.6%)
-$4.86 M(-2.5%)
-$18.46 M(+12.6%)
Sep 2021
-
-$4.99 M(-2.7%)
-$16.40 M(+20.0%)
Jun 2021
-
-$5.13 M(+47.4%)
-$13.66 M(+27.7%)
Mar 2021
-
-$3.48 M(+24.0%)
-$10.70 M(+26.7%)
Dec 2020
-$8.45 M(+7.9%)
-$2.80 M(+24.3%)
-$8.45 M(+6.3%)
Sep 2020
-
-$2.26 M(+4.2%)
-$7.95 M(+4.7%)
Jun 2020
-
-$2.17 M(+77.5%)
-$7.59 M(+5.3%)
Mar 2020
-
-$1.22 M(-47.1%)
-$7.21 M(-7.9%)
Dec 2019
-$7.83 M(+7.4%)
-$2.31 M(+21.3%)
-$7.83 M(+3.8%)
Sep 2019
-
-$1.90 M(+6.6%)
-$7.54 M(-2.2%)
Jun 2019
-
-$1.78 M(-3.2%)
-$7.71 M(-0.9%)
Mar 2019
-
-$1.84 M(-8.7%)
-$7.78 M(+6.8%)
Dec 2018
-$7.29 M(-2.4%)
-$2.02 M(-2.4%)
-$7.29 M(+2.1%)
Sep 2018
-
-$2.07 M(+11.7%)
-$7.14 M(+3.0%)
Jun 2018
-
-$1.85 M(+37.3%)
-$6.93 M(-4.6%)
Mar 2018
-
-$1.35 M(-27.9%)
-$7.26 M(-2.8%)
Dec 2017
-$7.47 M(-36.6%)
-$1.87 M(+0.8%)
-$7.47 M(-11.5%)
Sep 2017
-
-$1.86 M(-15.1%)
-$8.44 M(-11.4%)
Jun 2017
-
-$2.19 M(+40.6%)
-$9.53 M(-7.5%)
Mar 2017
-
-$1.55 M(-45.2%)
-$10.30 M(-12.6%)
Dec 2016
-$11.79 M(-17.8%)
-$2.84 M(-3.6%)
-$11.79 M(-4.3%)
Sep 2016
-
-$2.95 M(-0.6%)
-$12.33 M(+2.0%)
Jun 2016
-
-$2.96 M(-2.5%)
-$12.09 M(-3.1%)
Mar 2016
-
-$3.04 M(-9.9%)
-$12.47 M(-13.0%)
Dec 2015
-$14.34 M(-26.0%)
-$3.37 M(+24.5%)
-$14.34 M(-9.0%)
Sep 2015
-
-$2.71 M(-19.1%)
-$15.77 M(-12.2%)
Jun 2015
-
-$3.35 M(-31.9%)
-$17.96 M(-7.5%)
Mar 2015
-
-$4.91 M(+2.4%)
-$19.43 M(+0.2%)
Dec 2014
-$19.39 M(+90.9%)
-$4.80 M(-2.2%)
-$19.39 M(+6.8%)
Sep 2014
-
-$4.91 M(+2.0%)
-$18.15 M(-0.5%)
Jun 2014
-
-$4.81 M(-1.2%)
-$18.24 M(+52.8%)
Mar 2014
-
-$4.87 M(+36.8%)
-$11.94 M(+17.6%)
Dec 2013
-$10.15 M
-$3.56 M(-28.9%)
-$10.15 M(-10.6%)
Sep 2013
-
-$5.00 M(-435.4%)
-$11.36 M(+37.8%)
Jun 2013
-
$1.49 M(-148.4%)
-$8.24 M(-38.1%)
DateAnnualQuarterlyTTM
Mar 2013
-
-$3.08 M(-35.3%)
-$13.31 M(+1.0%)
Dec 2012
-$13.19 M(-13.5%)
-$4.76 M(+152.1%)
-$13.19 M(+9.2%)
Sep 2012
-
-$1.89 M(-47.2%)
-$12.08 M(-11.4%)
Jun 2012
-
-$3.58 M(+21.0%)
-$13.63 M(+0.2%)
Mar 2012
-
-$2.96 M(-19.2%)
-$13.61 M(-10.7%)
Dec 2011
-$15.24 M(-4.9%)
-$3.66 M(+6.2%)
-$15.24 M(+3.3%)
Sep 2011
-
-$3.44 M(-3.0%)
-$14.76 M(-2.4%)
Jun 2011
-
-$3.55 M(-22.6%)
-$15.12 M(-2.5%)
Mar 2011
-
-$4.59 M(+44.6%)
-$15.50 M(-3.3%)
Dec 2010
-$16.02 M(-18.1%)
-$3.17 M(-16.7%)
-$16.02 M(-6.8%)
Sep 2010
-
-$3.81 M(-3.2%)
-$17.19 M(+4.1%)
Jun 2010
-
-$3.93 M(-23.0%)
-$16.50 M(-15.9%)
Mar 2010
-
-$5.11 M(+17.8%)
-$19.62 M(+0.2%)
Dec 2009
-$19.57 M(-51.5%)
-$4.34 M(+38.8%)
-$19.57 M(-15.6%)
Sep 2009
-
-$3.12 M(-55.7%)
-$23.18 M(-38.5%)
Jun 2009
-
-$7.04 M(+39.1%)
-$37.70 M(-3.8%)
Mar 2009
-
-$5.06 M(-36.3%)
-$39.20 M(-2.9%)
Dec 2008
-$40.39 M(+67.9%)
-$7.94 M(-55.0%)
-$40.39 M(-7.8%)
Sep 2008
-
-$17.65 M(+106.5%)
-$43.80 M(+44.2%)
Jun 2008
-
-$8.54 M(+36.7%)
-$30.36 M(+19.5%)
Mar 2008
-
-$6.25 M(-44.9%)
-$25.41 M(+5.7%)
Dec 2007
-$24.05 M(-17.8%)
-$11.35 M(+169.4%)
-$24.05 M(+31.9%)
Sep 2007
-
-$4.21 M(+17.2%)
-$18.23 M(-6.3%)
Jun 2007
-
-$3.60 M(-26.5%)
-$19.45 M(-14.7%)
Mar 2007
-
-$4.89 M(-11.7%)
-$22.80 M(-22.1%)
Dec 2006
-$29.26 M(+62.1%)
-$5.54 M(+1.9%)
-$29.26 M(+3.2%)
Sep 2006
-
-$5.43 M(-21.8%)
-$28.36 M(+9.5%)
Jun 2006
-
-$6.94 M(-38.8%)
-$25.91 M(+7.9%)
Mar 2006
-
-$11.35 M(+144.6%)
-$24.01 M(+33.0%)
Dec 2005
-$18.05 M(-54.4%)
-$4.64 M(+55.9%)
-$18.05 M(-17.2%)
Sep 2005
-
-$2.98 M(-41.0%)
-$21.80 M(-15.0%)
Jun 2005
-
-$5.04 M(-6.4%)
-$25.65 M(-3.9%)
Mar 2005
-
-$5.39 M(-35.7%)
-$26.69 M(-32.6%)
Dec 2004
-$39.59 M(+114.5%)
-$8.39 M(+22.8%)
-$39.59 M(+8.5%)
Sep 2004
-
-$6.83 M(+12.2%)
-$36.49 M(+8.5%)
Jun 2004
-
-$6.09 M(-66.7%)
-$33.64 M(+2.2%)
Mar 2004
-
-$18.28 M(+245.4%)
-$32.90 M(+78.2%)
Dec 2003
-$18.46 M(-5.1%)
-$5.29 M(+33.2%)
-$18.46 M(+40.2%)
Sep 2003
-
-$3.98 M(-25.6%)
-$13.16 M(+43.3%)
Jun 2003
-
-$5.35 M(+39.1%)
-$9.19 M(+139.1%)
Mar 2003
-
-$3.84 M
-$3.84 M
Dec 2002
-$19.45 M(-0.3%)
-
-
Dec 2001
-$19.51 M(+50.8%)
-
-
Dec 2000
-$12.94 M(-106.7%)
-
-
Jan 1994
$193.30 M(+71.1%)
-
-
Jan 1993
$113.00 M
-
-

FAQ

  • What is Cyclacel Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals annual net income year-on-year change?
  • What is Cyclacel Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals quarterly net income year-on-year change?
  • What is Cyclacel Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals TTM net income year-on-year change?

What is Cyclacel Pharmaceuticals annual net profit?

The current annual net income of CYCC is -$22.55 M

What is the all time high annual net income for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high annual net profit is $193.30 M

What is Cyclacel Pharmaceuticals annual net income year-on-year change?

Over the past year, CYCC annual net profit has changed by -$1.36 M (-6.40%)

What is Cyclacel Pharmaceuticals quarterly net profit?

The current quarterly net income of CYCC is -$1.96 M

What is the all time high quarterly net income for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high quarterly net profit is $1.49 M

What is Cyclacel Pharmaceuticals quarterly net income year-on-year change?

Over the past year, CYCC quarterly net profit has changed by +$3.31 M (+62.87%)

What is Cyclacel Pharmaceuticals TTM net profit?

The current TTM net income of CYCC is -$13.43 M

What is the all time high TTM net income for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high TTM net profit is -$3.84 M

What is Cyclacel Pharmaceuticals TTM net income year-on-year change?

Over the past year, CYCC TTM net profit has changed by +$9.12 M (+40.45%)